O	0	4	Role	Role	NN	B-NP
O	5	7	of	of	IN	B-PP
B-Cellular_component	8	17	telomeres	telomere	NNS	B-NP
O	18	20	in	in	IN	B-PP
B-Multi-tissue_structure	21	29	vascular	vascular	JJ	B-NP
O	30	40	senescence	senescence	NN	I-NP
O	40	41	.	.	.	O

B-Cellular_component	42	51	Telomeres	Telomere	NNS	B-NP
O	52	55	are	be	VBP	B-VP
O	56	59	DNA	DNA	NN	B-NP
O	60	67	regions	region	NNS	I-NP
O	68	76	composed	compose	VBN	B-VP
O	77	79	of	of	IN	B-PP
O	80	86	TTAGGG	TTAGGG	NN	B-NP
O	87	94	repeats	repeat	NNS	I-NP
O	95	99	that	that	WDT	B-NP
O	100	103	are	be	VBP	B-VP
O	104	111	located	located	JJ	B-ADJP
O	112	114	at	at	IN	B-PP
O	115	118	the	the	DT	B-NP
O	119	123	ends	end	NNS	I-NP
O	124	126	of	of	IN	B-PP
B-Cellular_component	127	138	chromosomes	chromosome	NNS	B-NP
O	138	139	.	.	.	O

O	140	148	Specific	Specific	JJ	B-NP
O	149	157	proteins	protein	NNS	I-NP
O	158	167	associate	associate	VBP	B-VP
O	168	172	with	with	IN	B-PP
O	173	176	the	the	DT	B-NP
B-Cellular_component	177	186	telomeres	telomere	NNS	I-NP
O	187	190	and	and	CC	O
O	191	195	form	form	VB	B-VP
O	196	199	non	non	AFX	B-NP
O	199	200	-	-	HYPH	O
O	200	211	nucleosomal	nucleosomal	JJ	B-NP
O	212	215	DNA	DNA	NN	I-NP
O	215	216	-	-	HYPH	B-NP
O	216	223	protein	protein	NN	I-NP
O	224	233	complexes	complex	NNS	I-NP
O	234	238	that	that	WDT	B-NP
O	239	244	serve	serve	VBP	B-VP
O	245	247	as	as	IN	B-PP
O	248	258	protective	protective	JJ	B-NP
O	259	263	caps	cap	NNS	I-NP
O	264	267	for	for	IN	B-PP
O	268	271	the	the	DT	B-NP
B-Cellular_component	272	282	chromosome	chromosome	NN	I-NP
O	283	287	ends	end	VBZ	B-VP
O	287	288	.	.	.	O

O	289	294	There	There	EX	B-NP
O	295	297	is	be	VBZ	B-VP
O	298	310	accumulating	accumulate	VBG	I-VP
O	311	319	evidence	evidence	NN	B-NP
O	320	324	that	that	IN	B-SBAR
O	325	336	progressive	progressive	JJ	B-NP
B-Cellular_component	337	345	telomere	telomere	NN	I-NP
O	346	356	shortening	shortening	NN	I-NP
O	357	359	is	be	VBZ	B-VP
O	360	367	closely	closely	RB	B-ADJP
O	368	375	related	related	JJ	I-ADJP
O	376	378	to	to	TO	B-PP
B-Anatomical_system	379	393	cardiovascular	cardiovascular	JJ	B-NP
O	394	401	disease	disease	NN	I-NP
O	401	402	.	.	.	O

O	403	406	For	For	IN	B-PP
O	407	414	example	example	NN	B-NP
O	414	415	,	,	,	O
B-Cell	416	424	vascular	vascular	JJ	B-NP
I-Cell	425	429	cell	cell	NN	I-NP
O	430	440	senescence	senescence	NN	I-NP
O	441	444	has	have	VBZ	B-VP
O	445	449	been	be	VBN	I-VP
O	450	458	reported	report	VBN	I-VP
O	459	461	to	to	TO	I-VP
O	462	467	occur	occur	VB	I-VP
O	468	470	in	in	IN	B-PP
O	471	476	human	human	JJ	B-NP
B-Pathological_formation	477	492	atherosclerotic	atherosclerotic	JJ	I-NP
I-Pathological_formation	493	500	lesions	lesion	NNS	I-NP
O	501	504	and	and	CC	O
O	505	509	this	this	DT	B-NP
O	510	516	change	change	NN	I-NP
O	517	519	is	be	VBZ	B-VP
O	520	530	associated	associate	VBN	I-VP
O	531	535	with	with	IN	B-PP
B-Cellular_component	536	544	telomere	telomere	NN	B-NP
O	545	555	shortening	shortening	NN	I-NP
O	555	556	.	.	.	O

O	557	567	Impairment	Impairment	NN	B-NP
O	568	570	of	of	IN	B-PP
B-Cellular_component	571	579	telomere	telomere	NN	B-NP
O	580	589	integrity	integrity	NN	I-NP
O	590	596	causes	cause	VBZ	B-VP
B-Multi-tissue_structure	597	605	vascular	vascular	JJ	B-NP
O	606	617	dysfunction	dysfunction	NN	I-NP
O	617	618	,	,	,	O
O	619	624	which	which	WDT	B-NP
O	625	627	is	be	VBZ	B-VP
O	628	637	prevented	prevent	VBN	I-VP
O	638	640	by	by	IN	B-PP
O	641	644	the	the	DT	B-NP
O	645	655	activation	activation	NN	I-NP
O	656	658	of	of	IN	B-PP
O	659	669	telomerase	telomerase	NN	B-NP
O	669	670	.	.	.	O

O	671	675	Mice	Mouse	NNS	B-NP
O	676	680	with	with	IN	B-PP
O	681	686	short	short	JJ	B-NP
B-Cellular_component	687	696	telomeres	telomere	NNS	I-NP
O	697	704	develop	develop	VBP	B-VP
O	705	717	hypertension	hypertension	NN	B-NP
O	718	721	and	and	CC	O
O	722	729	exhibit	exhibit	VBP	B-VP
O	730	738	impaired	impaired	JJ	B-NP
O	739	757	neovascularization	neovascularization	NN	I-NP
O	757	758	.	.	.	O

O	759	764	Short	Short	JJ	B-NP
B-Cellular_component	765	774	telomeres	telomere	NNS	I-NP
O	775	779	have	have	VBP	B-VP
O	780	784	also	also	RB	I-VP
O	785	789	been	be	VBN	I-VP
O	790	798	reported	report	VBN	I-VP
O	799	801	in	in	IN	B-PP
O	802	805	the	the	DT	B-NP
B-Cell	806	816	leukocytes	leukocyte	NNS	I-NP
O	817	819	of	of	IN	B-PP
O	820	828	patients	patient	NNS	B-NP
O	829	833	with	with	IN	B-PP
B-Anatomical_system	834	848	cardiovascular	cardiovascular	JJ	B-NP
O	849	856	disease	disease	NN	I-NP
O	857	859	or	or	CC	O
O	860	867	various	various	JJ	B-NP
B-Anatomical_system	868	882	cardiovascular	cardiovascular	JJ	I-NP
O	883	887	risk	risk	NN	I-NP
O	888	895	factors	factor	NNS	I-NP
O	895	896	.	.	.	O

O	897	905	Although	Although	IN	B-SBAR
O	906	908	it	it	PRP	B-NP
O	909	916	remains	remain	VBZ	B-VP
O	917	924	unclear	unclear	JJ	B-ADJP
O	925	932	whether	whether	IN	B-SBAR
O	933	938	short	short	JJ	B-NP
B-Cellular_component	939	948	telomeres	telomere	NNS	I-NP
O	949	957	directly	directly	RB	B-ADVP
O	958	963	cause	cause	VB	B-VP
B-Anatomical_system	964	978	cardiovascular	cardiovascular	JJ	B-NP
O	979	986	disease	disease	NN	I-NP
O	986	987	,	,	,	O
O	988	1000	manipulation	manipulation	NN	B-NP
O	1001	1003	of	of	IN	B-PP
B-Cellular_component	1004	1012	telomere	telomere	NN	B-NP
O	1013	1021	function	function	NN	I-NP
O	1022	1024	is	be	VBZ	B-VP
O	1025	1036	potentially	potentially	RB	B-ADVP
O	1037	1039	an	an	DT	B-NP
O	1040	1050	attractive	attractive	JJ	I-NP
O	1051	1059	strategy	strategy	NN	I-NP
O	1060	1063	for	for	IN	B-PP
O	1064	1067	the	the	DT	B-NP
O	1068	1077	treatment	treatment	NN	I-NP
O	1078	1080	of	of	IN	B-PP
B-Multi-tissue_structure	1081	1089	vascular	vascular	JJ	B-NP
O	1090	1100	senescence	senescence	NN	I-NP
O	1100	1101	.	.	.	O

